Adaptimmune Therapeutics News

Adaptimmune Therapeutics | 8-K: Current report

May 14 07:39 ET

Adaptimmune Therapeutics | 8-K: Current report

Apr 12 08:07 ET

Adaptimmune Therapeutics | DEF 14A: Definitive information statements

Apr 11 08:04 ET

Adaptimmune Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 1 08:06 ET

Adaptimmune Therapeutics | 8-K: Current report

Mar 6 07:08 ET

Adaptimmune Therapeutics | 8-K: Current report

Feb 27 08:16 ET

Adaptimmune Therapeutics | 8-K: Current report

Feb 16 16:10 ET

Adaptimmune Therapeutics | 8-K: Current report

Jan 31 17:13 ET

Adaptimmune Therapeutics | 8-K: Current report

Jan 4 00:00 ET

Adaptimmune Therapeutics | 8-K: Current report

Dec 6, 2023 07:13 ET

Adaptimmune Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 30, 2023 16:16 ET

Adaptimmune Therapeutics | 8-K: Current report

Nov 14, 2023 07:30 ET

Adaptimmune Therapeutics | 8-K: Current report

Nov 8, 2023 07:37 ET

Adaptimmune Therapeutics | 8-K: Current report

Nov 3, 2023 16:15 ET

Adaptimmune Therapeutics | 8-K: Current report

Oct 31, 2023 08:07 ET

Adaptimmune Therapeutics | 8-K: Current report

Aug 31, 2023 17:19 ET

Adaptimmune Therapeutics | 8-K/A: Current report (Amendment)

Aug 10, 2023 16:05 ET

Adaptimmune Therapeutics | 8-K: Adaptimmune Reports Second Quarter Financial Results and Business Update

Aug 9, 2023 07:42 ET

Adaptimmune Therapeutics | S-8 POS: S-8 POS

Jun 29, 2023 16:54 ET

Adaptimmune Therapeutics | S-8 POS: S-8 POS

Jun 29, 2023 16:48 ET